BridgeBio to Report Second Quarter 2026 Financial Results and Commercial Updates on August 10, 2026 at 4:30 pm ET

Rhea-AI Summary

BridgeBio (Nasdaq: BBIO) announced that it will release its second quarter 2026 financial results and business update after the market closes on Monday, August 10, 2026. The company will host a conference call to discuss the financial results and program updates at 4:30 pm ET the same day.

According to BridgeBio, investors can access a live webcast of the presentation via the “Events & Presentations” page in the Investors section of its website, with a replay available for 30 days. Participants must register online through the provided webcast link. The company also highlights its focus on developing medicines for genetic conditions using a decentralized hub-and-spoke R&D model.

Market Context

BridgeBio’s prior earnings-date notices produced 24-hour reactions of 0.24% and 0.80%. That record p...

Analysis

BridgeBio’s prior earnings-date notices produced 24-hour reactions of 0.24% and 0.80%. That record provides context for this scheduling notice, while Net Selling insider activity and moderate short positioning are additional risk factors to watch when results arrive.

Key Figures

Reporting period: second quarter 2026 Results release date: August 10, 2026 Conference call time: 4:30 pm ET +1 more

4 metrics

Reporting period second quarter 2026 Financial results and business update

Results release date August 10, 2026 After market close

Conference call time 4:30 pm ET August 10, 2026

Webcast replay 30 days Available following the event

Previous Earnings date Reports

2 past events · Latest: Apr 30 (Neutral)

Same Type Pattern 2 events

Date	Event	Sentiment	24h Move	Catalyst
Apr 30	earnings date	Neutral	+0.2%	Announced first-quarter results and commercial updates scheduled for May 7
Feb 17	earnings date	Neutral	+0.8%	Announced fourth-quarter and full-year results scheduled for February 24

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Both prior earnings-date announcements were followed by positive 24-hour reactions of 0.24% and 0.80%.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PALO ALTO, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, today announced that it will release its second quarter 2026 financial results and business update after the market closes on Monday, August 10, 2026. BridgeBio will host a conference call to discuss the financial results and program updates at 4:30 pm ET the same day.

To access the live webcast of BridgeBio’s presentation, please visit the “Events & Presentations” page within the Investors section of the BridgeBio website at investor.bridgebio.com/events-and-presentations/. A replay of the webcast will be available on the BridgeBio website for 30 days following the event.

Participants may access the webcast by registering online using the following link, here.

About BridgeBio Pharma, Inc.
BridgeBio exists to develop transformative medicines for genetic conditions. Millions of people worldwide living with genetic conditions lack treatment options, often because drug development for small patient populations can be commercially challenging. We aim to bridge the gap between advancements in genetic science and meaningful medicines for underserved patient populations. Our decentralized, hub-and-spoke model is designed for speed, precision, and scalability. Autonomous and empowered teams focus on individual conditions, while a central hub provides the clinical, regulatory, and commercial capabilities needed to bring innovation to market. For more information, visit bridgebio.com and follow us on LinkedIn, X, Facebook, Instagram, YouTube, and TikTok.

BridgeBio Media Contact:
Bubba Murarka, Executive Vice President
contact@bridgebio.com   
(650)-789-8220

BridgeBio Investor Contact:
Kristen Kelleher, Director, Investor Relations
ir@bridgebio.com

FAQ

When will BridgeBio (BBIO) report its Q2 2026 financial results?

BridgeBio plans to report its Q2 2026 financial results on Monday, August 10, 2026, after the market closes. According to BridgeBio, the release will be accompanied by a business update and conference call that afternoon.

What time is BridgeBio's Q2 2026 earnings conference call on August 10, 2026?

BridgeBio has scheduled its Q2 2026 financial results and program update call for 4:30 pm ET on August 10, 2026. According to BridgeBio, the call will follow the after-market release of its quarterly results.

How can investors access the BridgeBio (BBIO) Q2 2026 earnings webcast?

Investors can access the BridgeBio Q2 2026 webcast via the “Events & Presentations” page in the Investors section of its website. According to BridgeBio, participants must register online through the provided webcast link before joining.

Will a replay be available for BridgeBio's Q2 2026 earnings webcast?

Yes, a replay of BridgeBio’s Q2 2026 earnings webcast will be available on the company’s website for 30 days. According to BridgeBio, the replay can be accessed through the same Investors “Events & Presentations” section.

Where can I find more investor information and updates about BridgeBio (NASDAQ: BBIO)?

Investor information and updates for BridgeBio are available in the Investors section of bridgebio.com. According to BridgeBio, this includes events, presentations, webcasts, and contact details for its investor relations team.